International Charter of principles for sharing bio-specimens and data
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
There is a growing international agreement on the need to provide greater access to research data and bio-specimen collections to optimize their long-term value and exploit their potential for health discovery and validation. This is especially evident for rare disease research. Currently, the rising value of data and bio-specimen collections does not correspond with an equal increase in data/sample-sharing and data/sample access. Contradictory legal and ethical frameworks across national borders are obstacles to effective sharing: more specifically, the absence of an integrated model proves to be a major logistical obstruction. The Charter intends to amend the obstacle by providing both the ethical foundations on which data sharing should be based, as well as a general Material and Data Transfer Agreement (MTA/DTA). This Charter is the result of a careful negotiation of different stakeholders' interest and is built on earlier consensus documents and position statements, which provided the general international legal framework. Further to this, the Charter provides tools that may help accelerate sharing. The Charter has been formulated to serve as an enabling tool for effective and transparent data and bio-specimen sharing and the general MTA/DTA constitutes a mechanism to ensure uniformity of access across projects and countries, and may be regarded as a consistent basic agreement for addressing data and material sharing globally. The Charter is forward looking in terms of emerging issues from the perspective of a multi-stakeholder group, and where possible, provides strategies that may address these issues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Should donors be allowed to give broad consent to future biobank research?
Hansson, M. G., Dillner, J., Bartram, C. R., Carlson, J. A., & Helgesson, G. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70618-0 · Cited by 382
Self-citationFrom patients to partners: participant-centric initiatives in biomedical research
Kaye, J., Curren, L., Anderson, N., Edwards, K., Fullerton, S. M., Kanellopoulou, N., Lund, D., MacArthur, D. G., Mascalzoni, D., Shepherd, J., et al. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3218 · Cited by 293
Self-citationThe tension between data sharing and the protection of privacy in genomics research
Kaye, J. (2012) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-082410-101454 · Cited by 240
Biobanks and Blanket Consent: The Proper Place of the Public Good and Public Perception Rationales
Caulfield, T. (2007) · King's Law Journal · doi:10.1080/09615768.2007.11427674 · Cited by 96
Donors Perceptions of Consent to and Feedback from Biobank Research: Time to Acknowledge Diversity?
Hoeyer, K. (2010) · Public Health Genomics · doi:10.1159/000262329 · Cited by 77
Cited by
International Cooperation to Enable the Diagnosis of All Rare Genetic Diseases
Boycott, K. M., Rath, A., Chong, J. X., Hartley, T., Alkuraya, F. S., Baynam, G., Brookes, A. J., Brudno, M., Carracedo, A., den Dunnen, J. T., et al. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.04.003 · Cited by 447
Self-citationComputer-Aided Drug Design and Drug Discovery: A Prospective Analysis
Niazi, S. K., & Mariam, Z. (2023) · Pharmaceuticals · doi:10.3390/ph17010022 · Cited by 336
Digital pathology and computational image analysis in nephropathology
Barisoni, L., Lafata, K. J., Hewitt, S. M., Madabhushi, A., & Balis, U. G. J. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0321-6 · Cited by 264
Grady, C., Cummings, S. R., Rowbotham, M. C., McConnell, M. V., Ashley, E. A., & Kang, G. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1603773 · Cited by 213
Big Data’s Role in Precision Public Health
Dolley, S. (2018) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00068 · Cited by 203
Recommendations for Improving the Quality of Rare Disease Registries
Kodra, Y., Weinbach, J., Posada-de-la-Paz, M., Coi, A., Lemonnier, S. L., Van Enckevort, D., Roos, M., Jacobsen, A., Cornet, R., Ahmed, S. F., et al. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15081644 · Cited by 189
“Consequently, helping data providers identify relevant ethical and legal requirements and how these can be addressed is an essential, but frequently neglected, step when removing possible hurdles to data and sample sharing in the life sciences [19,20].”
BackgroundSelf-citationProgress in Rare Diseases Research 2010–2016: An IRDiRC Perspective
Dawkins, H. J. S., Draghia‐Akli, R., Lasko, P., Lau, L. P. L., Jonker, A. H., Cutillo, C. M., Rath, A., Boycott, K. M., Baynam, G., Lochmüller, H., et al. (2018) · Clinical and Translational Science · doi:10.1111/cts.12501 · Cited by 178
Self-citationShabani, M., & Borry, P. (2018) · European Journal of Human Genetics · doi:10.1038/s41431-017-0045-7 · Cited by 170
“Given that the use of identifiable data is important at times such as for epidemiological research [21, 25], pseudonymization can be a restricting factor for use of genetic data under research exemption.”
BackgroundMostert, M., Bredenoord, A. L., Biesaart, M. C. I. H., & van Delden, J. J. M. (2016) · European Journal of Human Genetics · doi:10.1038/ejhg.2015.239 · Cited by 143
Ethical sharing of health data in online platforms - which values should be considered?
Riso, B., Tupasela, A., Vears, D. F., Felzmann, H., Cockbain, J., Loi, M., Kongsholm, N. C. H., Zullo, S., & Rakic, V. (2017) · Life Sciences, Society and Policy · doi:10.1186/s40504-017-0060-z · Cited by 44
“Without an integrated model or agreement on the core values enshrined in sharing, we cannot achieve logistical fluency (Mascalzoni et al. 2014).”
BackgroundA distributed whole genome sequencing benchmark study
Corbett, R. D., Eveleigh, R., Whitney, J., Barai, N., Bourgey, M., Chuah, E., Johnson, J., Moore, R. A., Moradin, N., Mungall, K. L., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.612515 · Cited by 10
Metadata
- Authors
- Mascalzoni, D., Dove, E. S., Rubinstein, Y., Dawkins, H. J. S., Kole, A., McCormack, P., Woods, S., Riess, O., Schaefer, F., Lochmüller, H., Knoppers, B. M., & Hansson, M.
- Venue
- European Journal of Human Genetics
- Published
- 2014-09-24
- Volume
- 23
- Issue
- 6
- Pages
- 721-728
- ISSN
- 1018-4813 (ISSN-L)
- 1476-5438
- OpenAlex
- W2076005227
- Cited by
- 156
- References
- 5
- FWCI
- 18.38
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.